drugset / Trial / NCT06987084

Bryophyllum Pinnatum Tea as a Novel Treatment for Recurrent Kidney Stone Formers

NCT06987084 ↗

Phase 0 Enrolling by invitation 25 enrolled Indra Gupta
RandomizedCrossoverQuadruple-blindPrevention

Summary

The aim of this randomized placebo-controlled double-blind crossover clinical trial is to test the ability of a traditional tea made from the leaf of the Bryophyllum pinnatum (B. pinnatum) plant in decreasing urinary calcium content in patients with recurrent calcium-based kidney stones.

Timeline

Start
2024-11-07
Primary completion
2025-12-31
Completion
2025-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Bryophyllum pinnatum Traditional medicine (herbal / TCM) 250 ml —
Subject Bryophyllum pinnatum Traditional medicine (herbal / TCM) 24 g —